Philips, American College of Cardiology and MedAxiom collaborate to
shape the future of cardiovascular care delivery
March 11, 2021
Organizations to develop roadmap for hospitals, health systems
and practices to improve clinical, financial and operational
performance while transforming patient care
Amsterdam, the Netherlands and Washington, D.C., U.S. –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, the American College of Cardiology (ACC), whose mission
is to transform cardiovascular care and improve heart health, and
MedAxiom, an ACC company with the same mission, today announced a
collaboration to deliver timely and actionable information along
with guidance to align physicians, operations and finance
stakeholders. The goal of the collaboration is to drive significant
performance improvements in integrated cardiovascular care in terms
of the patient and care provider experience, clinical outcomes and
productivity.
Cardiovascular disease is the leading cause of death globally,
taking an estimated 17.9 million lives per year [1]. In the United
States alone, total costs of cardiovascular disease are expected to
reach $1.1 trillion in 2035, of which direct medical costs are
projected to reach $749 billion [2]. Providers who care for this
population face numerous challenges, including a lack of a model
for optimizing performance and a void of data or data that are not
actionable. To address these challenges, Philips will leverage its
cardiovascular R&D and clinical expertise, ACC will provide
knowledge that leverages the skill and expertise of more than
54,000 members, and MedAxiom will contribute premier organizational
performance solutions.
“The ACC is mission driven to transform cardiovascular care and
improve heart health, and we embrace innovative ways of supporting
clinicians and the entire cardiovascular care team,” said Cathleen
C. Gates, chief executive officer, ACC. “By combining Philips’
depth of knowledge in cardiac care delivery with ACC’s robust
guideline and clinical document offerings, we’re ensuring
clinicians have access to guideline-driven best practices in an
impactful way.”
“MedAxiom is excited to collaborate with the ACC and Philips to
bring together clinical leadership and strategic alignment aimed at
improving clinical, financial and operational outcomes for
cardiovascular service providers,” said Gerald Blackwell, MD, MBA,
FACC, president and chief executive officer, MedAxiom. “Given the
rapidly changing healthcare environment, we must leverage
innovative models designed not only to optimize the way care is
delivered and achieve the Quadruple Aim, but to truly transform
cardiovascular care.”
“As the delivery of cardiac care faces many challenges, we are
implementing integrated solutions and new approaches to help make
healthcare delivery more efficient and effective,” said Bert van
Meurs, Executive Vice President and Chief Business Leader of Image
Guided Therapy at Royal Philips. “By collaborating with ACC and
MedAxiom we will advance personalized, efficient and
clinically-smart cardiac care that drives optimal outcomes
throughout the patient journey.”
Philips Integrated Cardiovascular Solutions – combining systems,
devices, informatics and services – provide the clinical confidence
needed to deliver the right care at the right time. This powerful
ecosystem cuts across the full spectrum of cardiac services with
the goal of optimizing length of stay while reducing readmissions,
providing data integration for improved insights and procedural
performance. Learnings from this work alongside those provided by
the ACC and MedAxiom will empower cardiovascular service providers
with data, education and services to enable providers to optimize
efficiency and reduce total cost of care, while continuing to
provide the highest quality levels.
Breaking down silos; driving care transformation Built on
a foundation of aligned purpose, strategic fit and complementary
visions, collaboration between the organizations to bring forward
longitudinal solutions and next-generation business models in
cardiovascular care has already begun. Philips, the ACC and
MedAxiom have identified inadequacies exposed by COVID-19 and have
used this knowledge to help cardiovascular groups begin to reframe
their cardiovascular care delivery. Supporting this innovation is
the TRIAD Model, which since the fall of 2020 has brought together
physician, healthcare administrator and industry leaders to
innovate the delivery of cardiovascular care through shared
accountability and shared risk. A podcast series with insights from
participants in the initiative is available here.
[1]
https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1[2]
https://www.heart.org/-/media/files/get-involved/advocacy/burden-report-consumer-report.pdf?la=en
For further information, please contact:
For Philips:
Mark GrovesPhilips Global Press OfficeTel.: +31 631 639
916E-mail: mark.groves@philips.com
Avi DinesPhilips North AmericaTel: +1 781-690-3814E-mail:
avi.dines@philips.com
For ACC and MedAxiom:
Nicole NapoliTel: +1 202 375 6523E-mail: nnapoli@acc.org
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
About MedAxiomMedAxiom, an ACC Company, is the
cardiovascular community’s premier source for organizational
performance solutions. MedAxiom is transforming cardiovascular care
by combining the knowledge and power of 425+ cardiovascular
organization members, thousands of administrators, clinicians and
coders and 35+ industry partners. Through the delivery of
proprietary tools, smart data and proven strategies, MedAxiom helps
cardiovascular organizations achieve the Quadruple Aim of better
outcomes, lower costs, improved patient experience and improved
clinician experience. For additional information,
visit www.MedAxiom.com.
About ACCThe American College of Cardiology (ACC)
envisions a world where innovation and knowledge optimize
cardiovascular care and outcomes. As the professional home for the
entire cardiovascular care team, the mission of the College and its
54,000 members is to transform cardiovascular care and to improve
heart health. The ACC bestows credentials upon cardiovascular
professionals who meet stringent qualifications and leads in the
formation of health policy, standards and guidelines. The College
also provides professional medical education, disseminates
cardiovascular research through its world-renowned JACC Journals,
operates national registries to measure and improve care, and
offers cardiovascular accreditation to hospitals and institutions.
For more, visit acc.org.
- Philips Azurion TAVI procedure
- Philips Azurion with EPIQ CVxi
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024